{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:27:43Z","timestamp":1790832463265,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["10\/10\/23"],"award-info":[{"award-number":["10\/10\/23"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.cca.2024.119765","type":"journal-article","created":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T19:20:54Z","timestamp":1717788054000},"page":"119765","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The solute carrier family 26 member 9 modifies rapidly progressing cystic fibrosis associated with homozygous F508del CFTR mutation"],"prefix":"10.1016","volume":"561","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6965-8674","authenticated-orcid":false,"given":"Shiyu","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Rollins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Schmitz-Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahai","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruobing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj B.","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.cca.2024.119765_b0005","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1001\/jama.2023.8120","article-title":"Cystic fibrosis: a review","volume":"329","author":"Ong","year":"2023","journal-title":"J. Am. Med. Assoc."},{"issue":"2","key":"10.1016\/j.cca.2024.119765_b0010","doi-asserted-by":"crossref","first-page":"20","DOI":"10.32607\/actanaturae.11708","article-title":"Gene therapy for cystic fibrosis: recent advances and future prospects","volume":"15","author":"Lomunova","year":"2023","journal-title":"Acta Nat."},{"issue":"4","key":"10.1016\/j.cca.2024.119765_b0015","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jcf.2010.04.002","article-title":"Year-to-year changes in lung function in individuals with cystic fibrosis","volume":"9","author":"Liou","year":"2010","journal-title":"J. Cyst. Fibros."},{"issue":"6","key":"10.1016\/j.cca.2024.119765_b0020","doi-asserted-by":"crossref","DOI":"10.3390\/genes11060589","article-title":"The changing epidemiology of cystic fibrosis: incidence, survival and impact of the CFTR gene discovery","volume":"11","author":"Scotet","year":"2020","journal-title":"Genes (Basel)"},{"issue":"10","key":"10.1016\/j.cca.2024.119765_b0025","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1164\/rccm.200608-1164OC","article-title":"Heritability of lung disease severity in cystic fibrosis","volume":"175","author":"Vanscoy","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cca.2024.119765_b0030","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jcf.2019.11.001","article-title":"Genetic variation in CFTR and modifier loci may modulate cystic fibrosis disease severity","volume":"19","author":"Paranjapye","year":"2020","journal-title":"J. Cyst. Fibros."},{"issue":"10","key":"10.1016\/j.cca.2024.119765_b0035","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1164\/rccm.202209-1653OC","article-title":"Genetic modifiers of cystic fibrosis lung disease severity: whole-genome analysis of 7,840 patients","volume":"207","author":"Zhou","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cca.2024.119765_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.850261","article-title":"SLC6A14 impacts cystic fibrosis lung disease severity via mTOR and epithelial repair modulation","volume":"9","author":"Mercier","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"5","key":"10.1016\/j.cca.2024.119765_b0045","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1210\/clinem\/dgz102","article-title":"Genetic modifiers of cystic fibrosis-related diabetes have extensive overlap with type 2 diabetes and related traits","volume":"105","author":"Aksit","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.cca.2024.119765_b0050","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1165\/rcmb.2017-0166OC","article-title":"The epithelial sodium channel is a modifier of the long-term nonprogressive phenotype associated with F508del CFTR mutations","volume":"57","author":"Agrawal","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.cca.2024.119765_b0055","first-page":"7","article-title":"SLC6A14, an amino acid transporter, modifies the primary CF defect in fluid secretion","author":"Ahmadi","year":"2018","journal-title":"Elife"},{"issue":"6","key":"10.1016\/j.cca.2024.119765_b0060","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/MCP.0b013e3283121cdc","article-title":"Update on gene modifiers in cystic fibrosis","volume":"14","author":"Collaco","year":"2008","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"10","key":"10.1016\/j.cca.2024.119765_b0065","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.2337\/db13-0510","article-title":"Genetic modifiers of cystic fibrosis-related diabetes","volume":"62","author":"Blackman","year":"2013","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.cca.2024.119765_b0070","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/14728222.2018.1501361","article-title":"The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosis lung disease","volume":"22","author":"Moore","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"issue":"6","key":"10.1016\/j.cca.2024.119765_b0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005273","article-title":"Exome sequencing of phenotypic extremes identifies CAV2 and TMC6 as interacting modifiers of chronic pseudomonas aeruginosa infection in cystic fibrosis","volume":"11","author":"Emond","year":"2015","journal-title":"PLoS Genet."},{"issue":"8","key":"10.1016\/j.cca.2024.119765_b0080","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/ng.2344","article-title":"Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis","volume":"44","author":"Emond","year":"2012","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.cca.2024.119765_b0085","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41431-019-0401-x","article-title":"Unique bioinformatic approach and comprehensive reanalysis improve diagnostic yield of clinical exomes","volume":"27","author":"Schmitz-Abe","year":"2019","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.cca.2024.119765_b0090","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41421-020-00193-7","article-title":"Structural insights into the gating mechanism of human SLC26A9 mediated by its C-terminal sequence","volume":"6","author":"Chi","year":"2020","journal-title":"Cell Discov."},{"issue":"D1","key":"10.1016\/j.cca.2024.119765_b0095","doi-asserted-by":"crossref","first-page":"D1478","DOI":"10.1093\/nar\/gkad1061","article-title":"VarCards2: an integrated genetic and clinical database for ACMG-AMP variant-interpretation guidelines in the human whole genome","volume":"52","author":"Wang","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"6509","key":"10.1016\/j.cca.2024.119765_b0100","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.aaz1776","article-title":"The GTEx Consortium atlas of genetic regulatory effects across human tissues","volume":"369","author":"Consortium","year":"2020","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.cca.2024.119765_b0105","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"The genotype-tissue expression (GTEx) project","volume":"45","author":"Consortium","year":"2013","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.cca.2024.119765_b0110","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.devcel.2021.11.007","article-title":"A census of the lung: cell cards from LungMAP","volume":"57","author":"Sun","year":"2022","journal-title":"Dev. Cell"},{"key":"10.1016\/j.cca.2024.119765_b0115","article-title":"LungMAP portal ecosystem: systems-level exploration of the lung","author":"Gaddis","year":"2022","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.cca.2024.119765_b0120","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1038\/s41467-023-40173-5","article-title":"Guided construction of single cell reference for human and mouse lung","volume":"14","author":"Guo","year":"2023","journal-title":"Nat. Commun."},{"issue":"6534","key":"10.1016\/j.cca.2024.119765_b0125","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc3172","article-title":"Genomic, epigenomic, and biophysical cues controlling the emergence of the lung alveolus","volume":"371","author":"Zepp","year":"2021","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.cca.2024.119765_b0130","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00232-009-9165-5","article-title":"Slc26a9\u2013anion exchanger, channel and Na+ transporter","volume":"228","author":"Chang","year":"2009","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.cca.2024.119765_b0135","first-page":"8","article-title":"Cryo-EM structures and functional characterization of murine Slc26a9 reveal mechanism of uncoupled chloride transport","author":"Walter","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.cca.2024.119765_b0140","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev.med.58.071905.105316","article-title":"Airway surface dehydration in cystic fibrosis: pathogenesis and therapy","volume":"58","author":"Boucher","year":"2007","journal-title":"Annu. Rev. Med."},{"issue":"4","key":"10.1016\/j.cca.2024.119765_b0145","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMra1300109","article-title":"Origins of cystic fibrosis lung disease","volume":"372","author":"Stoltz","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.cca.2024.119765_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10245821","article-title":"Genetic modifying factors of cystic fibrosis phenotype: a challenge for modern medicine","volume":"10","author":"Butnariu","year":"2021","journal-title":"J. Clin. Med."},{"issue":"1\u20134","key":"10.1016\/j.cca.2024.119765_b0155","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000149780","article-title":"Characterization of SLC26A9, facilitation of Cl(-) transport by bicarbonate","volume":"22","author":"Loriol","year":"2008","journal-title":"Cell. Physiol. Biochem."},{"issue":"5","key":"10.1016\/j.cca.2024.119765_b0160","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/ng.2221","article-title":"Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis","volume":"44","author":"Sun","year":"2012","journal-title":"Nat. Genet."},{"issue":"10","key":"10.1016\/j.cca.2024.119765_b0165","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.ajhg.2022.09.004","article-title":"Pleiotropic modifiers of age-related diabetes and neonatal intestinal obstruction in cystic fibrosis","volume":"109","author":"Aksit","year":"2022","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.cca.2024.119765_b0170","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41525-022-00299-9","article-title":"Genetic evidence supports the development of SLC26A9 targeting therapies for the treatment of lung disease","volume":"7","author":"Gong","year":"2022","journal-title":"NPJ Genom. Med."},{"issue":"1","key":"10.1016\/j.cca.2024.119765_b0175","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1172\/JCI129833","article-title":"Increased expression of anion transporter SLC26A9 delays diabetes onset in cystic fibrosis","volume":"130","author":"Lam","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2024.119765_b0180","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3389\/fphar.2018.00828","article-title":"SLC26A9 gene is associated with lung function response to ivacaftor in patients with cystic fibrosis","volume":"9","author":"Corvol","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"20","key":"10.1016\/j.cca.2024.119765_b0185","first-page":"4590","article-title":"Cystic fibrosis gene modifier SLC26A9 modulates airway response to CFTR-directed therapeutics","volume":"25","author":"Strug","year":"2016","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.cca.2024.119765_b0190","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00439-013-1363-7","article-title":"Unraveling the complex genetic model for cystic fibrosis: pleiotropic effects of modifier genes on early cystic fibrosis-related morbidities","volume":"133","author":"Li","year":"2014","journal-title":"Hum. Genet."},{"issue":"10","key":"10.1016\/j.cca.2024.119765_b0195","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1172\/JCI60429","article-title":"SLC26A9-mediated chloride secretion prevents mucus obstruction in airway inflammation","volume":"122","author":"Anagnostopoulou","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.cca.2024.119765_b0200","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jcf.2021.02.007","article-title":"SLC26A9 SNP rs7512462 is not associated with lung disease severity or lung function response to ivacaftor in cystic fibrosis patients with G551D-CFTR","volume":"20","author":"Eastman","year":"2021","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.cca.2024.119765_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2023.147428","article-title":"Identification of single nucleotide variants in SLC26A9 gene in patients with cystic fibrosis (p.Phe508del homozygous) and its association to Orkambi(R) (Lumacaftor and Ivacaftor) response in vitro","volume":"871","author":"Santos","year":"2023","journal-title":"Gene"},{"issue":"6","key":"10.1016\/j.cca.2024.119765_b0210","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.bbadis.2019.01.029","article-title":"Extent of rescue of F508del-CFTR function by VX-809 and VX-770 in human nasal epithelial cells correlates with SNP rs7512462 in SLC26A9 gene in F508del\/F508del cystic fibrosis patients","volume":"1865","author":"Kmit","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"6","key":"10.1016\/j.cca.2024.119765_b0215","first-page":"577","article-title":"Characterization of the L683P mutation of SLC26A9 in Xenopus oocytes","volume":"1810","author":"Avella","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"10","key":"10.1016\/j.cca.2024.119765_b0220","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/humu.22382","article-title":"Characterization of SLC26A9 in patients with CF-like lung disease","volume":"34","author":"Bakouh","year":"2013","journal-title":"Hum. Mutat."},{"issue":"4","key":"10.1016\/j.cca.2024.119765_b0225","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1085\/jgp.200810097","article-title":"SLC26A9 is a constitutively active, CFTR-regulated anion conductance in human bronchial epithelia","volume":"133","author":"Bertrand","year":"2009","journal-title":"J. Gen. Physiol."},{"issue":"6","key":"10.1016\/j.cca.2024.119765_b0230","doi-asserted-by":"crossref","first-page":"L1147","DOI":"10.1152\/ajplung.00563.2020","article-title":"Separating the contributions of SLC26A9 and CFTR to anion secretion in primary human bronchial epithelia","volume":"321","author":"Larsen","year":"2021","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"6","key":"10.1016\/j.cca.2024.119765_b0235","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1002\/jcp.22967","article-title":"Differential contribution of SLC26A9 to Cl(-) conductance in polarized and non-polarized epithelial cells","volume":"227","author":"Ousingsawat","year":"2012","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.cca.2024.119765_b0240","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/jcp.22328","article-title":"SLC26A9 stimulates CFTR expression and function in human bronchial cell lines","volume":"226","author":"Avella","year":"2011","journal-title":"J. Cell. Physiol."},{"issue":"41","key":"10.1016\/j.cca.2024.119765_b0245","doi-asserted-by":"crossref","first-page":"28306","DOI":"10.1074\/jbc.M109.001669","article-title":"Slc26a9 is inhibited by the R-region of the cystic fibrosis transmembrane conductance regulator via the STAS domain","volume":"284","author":"Chang","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.cca.2024.119765_b0250","doi-asserted-by":"crossref","first-page":"L912","DOI":"10.1152\/ajplung.00178.2016","article-title":"The CFTR trafficking mutation F508del inhibits the constitutive activity of SLC26A9","volume":"312","author":"Bertrand","year":"2017","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"48","key":"10.1016\/j.cca.2024.119765_b0255","doi-asserted-by":"crossref","first-page":"18269","DOI":"10.1074\/jbc.RA119.010192","article-title":"The anion transporter SLC26A9 localizes to tight junctions and is degraded by the proteasome when co-expressed with F508del-CFTR","volume":"294","author":"Sato","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.cca.2024.119765_b0260","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202200313RR","article-title":"The SLC26A9 inhibitor S9\u2013A13 provides no evidence for a role of SLC26A9 in airway chloride secretion but suggests a contribution to regulation of ASL pH and gastric proton secretion","volume":"36","author":"Jo","year":"2022","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.cca.2024.119765_b0265","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s00424-014-1543-x","article-title":"Loss of Slc26a9 anion transporter alters intestinal electrolyte and HCO3(-) transport and reduces survival in CFTR-deficient mice","volume":"467","author":"Liu","year":"2015","journal-title":"Pflugers Arch."},{"issue":"7835","key":"10.1016\/j.cca.2024.119765_b0270","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41586-020-2922-4","article-title":"A molecular cell atlas of the human lung from single-cell RNA sequencing","volume":"587","author":"Travaglini","year":"2020","journal-title":"Nature"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124020175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124020175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T11:42:49Z","timestamp":1720957369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898124020175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":54,"alternative-id":["S0009898124020175"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2024.119765","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The solute carrier family 26 member 9 modifies rapidly progressing cystic fibrosis associated with homozygous F508del CFTR mutation","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2024.119765","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"119765"}}